Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HIRIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
INO80E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAOK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOC2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM219 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C16orf92 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM57B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDOA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP4C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBX6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on